American Health Packaging is recalling 1,948 cartons of Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, because the drug failed dissolution testing. This means the medication may not break down properly in the body, which could prevent it from being absorbed correctly to treat infections. The recalled capsules were distributed nationwide in 100-count cartons containing 10 blister cards.
If the medication fails to dissolve as required, the patient may not receive the full therapeutic dose. This could lead to a lack of effectiveness in treating bacterial infections, potentially allowing the infection to worsen or persist.
Contact healthcare provider and return product to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.